Keybank National Association OH Reduces Stake in UnitedHealth Group Incorporated $UNH

Keybank National Association OH decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.1% during the second quarter, HoldingsChannel.com reports. The firm owned 182,420 shares of the healthcare conglomerate’s stock after selling 25,104 shares during the period. Keybank National Association OH’s holdings in UnitedHealth Group were worth $56,910,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bayforest Capital Ltd raised its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares in the last quarter. O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 37 shares in the last quarter. Nova Wealth Management Inc. raised its position in shares of UnitedHealth Group by 339.1% in the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after buying an additional 78 shares in the last quarter. Finally, Cloud Capital Management LLC purchased a new stake in UnitedHealth Group during the first quarter valued at about $53,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 3.2%

UNH opened at $356.05 on Thursday. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market cap of $322.47 billion, a P/E ratio of 18.58, a P/E/G ratio of 2.37 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The business’s 50-day moving average price is $342.00 and its 200-day moving average price is $331.00.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period last year, the firm earned $7.15 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analyst Ratings Changes

UNH has been the topic of a number of research reports. Robert W. Baird restated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday. Finally, Truist Financial lifted their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Eighteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $395.64.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.